IPO GlycoMimetics (GLYC) is a biotechnology company focused on the discovery and development of drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. GlycoMimetics is focusing initial efforts on drug candidates for rare diseases that the company believes will qualify for orphan drug designation.
Get an advisory report for this company's Initial Public Offering
View this company's prospectus
Wednesday, November 6, 2013
Tuesday, November 5, 2013
IPOs 2013: Barracuda
IPO Barracuda Networks (CUDA) designs and delivers cloud-connected security and storage solutions offered on a subscription basis. Barracuda's customers work in all types of organizations, from mid-market businesses, governments and educational institutions, to departments or divisions within Fortune 2000 enterprises.
Get an advisory report for this company's Initial Public Offering
View this company's prospectus
Get an advisory report for this company's Initial Public Offering
View this company's prospectus
Subscribe to:
Comments (Atom)